To The Editor: Dr Bridge and colleagues1 performed a systematic review and meta-analysis of the risks and benefits of antidepressant medications for pediatric psychiatric disorders. It seems misleading to limit the issues of risk and harm to treatment-emergent suicidality, when in actual practice other adverse reactions that make these medications intolerable for young persons occur much more regularly.